Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  EMIS Group plc    EMIS   GB00B61D1Y04


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EMIS : Directorate Change

12/20/2019 | 02:56am EST
Directorate Change

Released : 20/12/19 07:00

RNS Number : 5459X
20 December 2019

20 December 2019

EMIS Group plc ('EMIS Group' or the 'Company')

Directorate change

EMIS Group, the UK leader in connected healthcare software and services, today announces the planned retirement of Mike O'Leary and is pleased to announce the appointment of Patrick De Smedt to the Board as an independent Non-executive Director and Chairman designate.

Mike will retire at the conclusion of the 2020 Annual General Meeting (AGM) on 6 May 2020, after nine years of service with EMIS Group as Chairman of the Board and of its nomination committee.

Patrick De Smedt will be formally appointed as an independent Non-executive Director on 1 January 2020 and will take over as Chairman of the Board and of its nomination committee on Mike's retirement.

Patrick has a wealth of international business experience including a diverse portfolio of Board appointments in public and private equity-backed companies varying in size up to multi-billion pound revenues. He was previously interim Chairman of KCOM Group plc during a period which included the successful sale of the company earlier this year. His entire executive career was spent in the software sector, primarily with Microsoft, across a range of management roles throughout Europe. His last executive role was as Chairman for Microsoft EMEA.He is currently Senior Independent Director of PageGroup plc, in addition to a number of private company roles.

Commenting on the appointment, Mike O'Leary, Chairman of EMIS Group, said:

'I am extremely pleased that Patrick has agreed to join our Board and to succeed me as Chairman. Patrick has a wealth of experience of the UK and global technology sector as well as of public company governance, which makes him eminently well-qualified to help the executive team take EMIS to the next level.'

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name: Patrick Jean-Marie De Smedt

Age: 64

Current Directorships:

Divitias HoldCo Ltd appointed 15 May 2018

PageGroup plc appointed 1 August 2015

Kodak Alaris Holdings Ltd appointed 1 June 2014

The Chancellery Residents Company Ltd appointed 24 November 2009

18 St. James Management Company Ltd appointed 4 November 2009

Directorships held in the past five years:

Nexinto Holding Ltd (4 December 2013 - 30 November 2017)
Victrex Plc (28 July 2008 - 9 February 2018)
Morgan Sindall Group Plc (1 December 2009 - 31 December 2018)
KCOM Group Plc (28 January 2016 - 1 August 2019)

Anite plc (26 September 2013 - 13 August 2015)

There are no further disclosures to be made in connection with Schedule Two of paragraph (g) of the AIM rules for companies in connection with this appointment.

- ENDS -

For further information, contact:

EMIS Group plc Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO


Numis Securities Limited (nominated adviser and broker) Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black

MHP Communications Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo

Information for investors, including analyst consensus forecasts, can be found on the Group's website at www.emisgroupplc.com/investors.

Notes to editors

EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and UK healthcare blockchain.

EMIS Group's brands include:

EMIS Health, supplying innovative and essential technology to 10,000 healthcare users, in the number one or number two market positions in each of its major markets;

Patient, the UK's leading independent provider of patient-centric medical and wellbeing information and related transactional services;

Egton, providing specialist ICT infrastructure, hardware and engineering services and non-clinical software into health and social care; and

Dovetail Lab, a health technology company developing blockchain software to facilitate the integration of healthcare data.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.


EMIS Group plc published this content on 20 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 December 2019 07:55:09 UTC

© Publicnow 2019
All news about EMIS GROUP PLC
03:16aBETTER PERFORMANCE IN THE SECOND HAL : a research report by Edison
01/21EMIS : FY20 Revenue, Adjusted Operating Profit To Remain Stable
2020Vodafone Idea Partners with Bajaj Finance for Financing Options for Smartphon..
2020Caixin, CITIC Capital to Sell Emerging Markets Data Unit for $180 Million
2020EMIS GROUP PLC : Ex-dividend day for interim dividend
2020EMIS : shortlisted for two AIM awards
2020EMIS GROUP PLC : half-yearly earnings release
2020FULL YEAR OUTLOOK MAINTAINED : a research report by Edison
2020EMIS GROUP PLC : Ex-dividend day for final dividend
2020EMIS : Final Results
More news
Sales 2020 159 M 217 M 217 M
Net income 2020 28,9 M 39,4 M 39,4 M
Net cash 2020 44,1 M 60,2 M 60,2 M
P/E ratio 2020 24,6x
Yield 2020 2,90%
Capitalization 710 M 974 M 968 M
EV / Sales 2020 4,19x
EV / Sales 2021 3,99x
Nbr of Employees 1 605
Free-Float 92,5%
Duration : Period :
EMIS Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 1 234,00 GBX
Last Close Price 1 130,00 GBX
Spread / Highest target 19,5%
Spread / Average Target 9,20%
Spread / Lowest Target 1,95%
EPS Revisions
Managers and Directors
Andrew John Thorburn Chief Executive Officer & Executive Director
Patrick Jean-Marie de Smedt Chairman
Peter John Southby Chief Financial Officer & Executive Director
Shaun O’Hanlon Chief Medical Officer
Pete Malcolm Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
OMNICELL, INC.0.33%5 095
SECTRA AB (PUBL)1.09%3 445